Enovix (NASDAQ:ENVX) Rating Increased to Strong-Buy at Loop Capital

Enovix (NASDAQ:ENVX) was upgraded by analysts at Loop Capital to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports.

A number of other research analysts have also recently issued reports on ENVX. Oppenheimer lowered their price target on shares of Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a research note on Wednesday, July 8th. JPMorgan Chase & Co. cut Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Benchmark cut their price target on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $25.00 price target on shares of Enovix in a research note on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $11.77.

Enovix Trading Up 8.6%

ENVX opened at $3.40 on Monday. The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46. Enovix has a 52 week low of $3.06 and a 52 week high of $14.21. The stock has a market cap of $746.13 million, a PE ratio of -4.20 and a beta of 2.32. The business has a 50 day moving average of $5.13 and a 200-day moving average of $5.78.

Enovix (NASDAQ:ENVX) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.02. The company had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.The firm’s revenue for the quarter was up 20.8% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Equities research analysts predict that Enovix will post -0.78 earnings per share for the current fiscal year.

Institutional Trading of Enovix

A number of institutional investors and hedge funds have recently bought and sold shares of ENVX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Enovix by 5.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company’s stock worth $722,000 after buying an additional 4,780 shares during the last quarter. NewEdge Advisors LLC grew its holdings in shares of Enovix by 10.4% during the first quarter. NewEdge Advisors LLC now owns 26,257 shares of the company’s stock valued at $193,000 after buying an additional 2,481 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Enovix by 65.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock valued at $8,351,000 after acquiring an additional 449,934 shares in the last quarter. Caxton Associates LLP bought a new stake in shares of Enovix during the first quarter valued at approximately $190,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Enovix by 18.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company’s stock worth $2,628,000 after acquiring an additional 55,676 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors.

Enovix News Roundup

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Buy upgrade and improving estimates: Zacks upgraded Enovix to Rank #2 (Buy), citing growing optimism about the company’s earnings outlook. Separately, Zacks said ENVX is technically oversold after a steep four-week decline, while analysts have been revising earnings estimates higher—factors that could support a near-term rebound. Enovix upgraded to Buy Why Enovix’s trend might reverse
• Positive Sentiment: CEO transition described as strategic continuity: Enovix said the leadership change is a “CEO transition, not a strategy transition,” reaffirmed its third-quarter 2026 guidance, and reported approximately $552 million in cash. The sizable cash balance may ease near-term financing concerns and support continued development. Enovix CEO transition webcast
• Neutral Sentiment: Unusually high trading activity in Enovix call options indicates elevated speculative interest, but the report does not establish whether investors are positioning for a sustained rally or further volatility. Enovix call option activity
• Negative Sentiment: Analyst downgrade and recent low: William Blair cut ENVX to Market Perform, and the stock recently reached a new 12-month low after the downgrade. Reports also attributed the broader decline in battery-development stocks to sharply higher Treasury yields, which pressure speculative companies. William Blair downgrades Enovix Higher yields pressure speculative growth stocks

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.